Forgot Password?

If you are Corporate user, please
click here
If you have a user ID already and cannot login, contact Customer Support
You can begin the registration process by clicking here

Welcome to the Kite, a Gilead Company
Cell Therapy External Research Program Application Portal

External Research Program

The Kite External Research Program provides support for collaborative and investigator sponsored research that advances medical and scientific knowledge in cell therapy. In considering applications for support we will consider the principal investigator and any sub-investigators qualifications, including direct cellular therapy experience with demonstrated ability to successfully conduct trials. Technical, operational, and logistical capabilities of the proposed investigational site will also be considered. The budget must be reasonable and appropriate for the proposed work.

Kite accepts unsolicited clinical and non-clinical study proposals that are developed, designed, and conducted by external investigators.

The Kite External Research Program is a limited program. Kite is currently interested in study proposals that address one of the following areas: Novel combinations, side effect / safety management combinations, orphan B-cell malignancies, earlier lines of therapy in high risk patients, B-cell mediated autoimmune disease, novel conditioning, and real world data.

Please contact your local Kite Medical Science Liaison (MSL) if you would like to discuss your concept or have questions. The terms under which Kite, or its affiliated companies, will provide support must be contained in a written agreement. Kite provides no guarantees that it will provide support for your proposal.

Submitting a Proposal

To submit a proposal, please login and complete the application form. If you need a user id, click the link to the left. The application form must be completed in full for consideration.

Please note, decisions will be communicated via email within 2-4 months of submission window closing.

MRC-00143 12/2018